NeoGenomics (NASDAQ:NEO) just reported results for the second quarter of 2024.
- NeoGenomics reported earnings per share of 3 cents.
- The company reported revenue of $164.50 million.
- This was 1.64% better than the analyst estimate for revenue of $161.85 million.